AUSTIN, Texas--(BUSINESS WIRE)--VMD Sciences, LLC, a pioneering company dedicated to accelerating biomedical innovation for pets, veterinarians, and pet owners, today announces the launch of its Expanded Access Programs (EAPs) for pets and livestock. In collaboration with community veterinarians and animal medicine developers, VMD Sciences aims to address unmet medical needs by providing access to groundbreaking, life-saving treatments..

德克萨斯州奥斯汀——（商业新闻短讯）——VMD Sciences，LLC是一家致力于为宠物、兽医和宠物主人加速生物医学创新的开创性公司，今天宣布推出针对宠物和牲畜的扩展获取计划（EAP）。VMD Sciences与社区兽医和动物医学开发人员合作，旨在通过提供开创性的救生治疗来解决未满足的医疗需求。。

Introducing animal Expanded Access Programs (EAPs)

引入动物扩展获取计划（EAP）

VMD Sciences’ animal Expanded Access Programs (EAPs) offer veterinarians and their patients access to cutting-edge treatment options that are often unavailable through standard channels. The company’s commitment to supporting responsible extra-label drug use unlocks the potential of advanced therapies to tackle the toughest veterinary medical challenges facing animals today.

VMD Sciences的动物扩展获取计划（EAP）为兽医及其患者提供了通过标准渠道通常无法获得的尖端治疗选择。该公司致力于支持负责任的标签外药物使用，释放了先进疗法的潜力，以应对当今动物面临的最严峻的兽医医学挑战。

Through these Expanded Access Programs, VMD Sciences helps ensure safe and compliant access to life-saving treatments that were previously unavailable. By working closely with veterinarians, the company aims to create new opportunities for improved health of pets and livestock..

通过这些扩展的获取计划，VMD Sciences有助于确保安全和合规地获取以前无法获得的救生治疗。通过与兽医密切合作，该公司旨在为改善宠物和牲畜的健康创造新的机会。。

A Response to Unmet Needs

对未满足需求的回应

“In today's world, the internet and online communities provide pet owners with a wealth of information about global medicines and their potential impact on animal diseases,” said Richard Falcha, President of VMD Sciences. “Unfortunately, some pet owners may turn to unlicensed or unethical sources in desperation, often without involving their veterinarians.

VMD Sciences总裁Richard Falcha表示：“在当今世界，互联网和在线社区为宠物主人提供了大量有关全球药物及其对动物疾病潜在影响的信息。”。“不幸的是，一些宠物主人可能会绝望地求助于未经许可或不道德的来源，通常没有兽医的参与。

Our mission is to provide safe, ethical, and compliant access to global veterinary medicines by collaborating closely with community veterinarians and veterinary pharmaceutical manufacturers. We assist with necessary regulatory filings to enable adherence to established global guidelines.”.

。我们协助进行必要的监管备案，以便遵守既定的全球准则。”。

Understanding Expanded Access Programs

了解扩展访问程序

Expanded Access Programs (EAPs), also known as Managed Access or “Compassionate Use” programs, have been widely utilized in human medicine to grant patients access to unlicensed therapies that address unmet medical needs through regulatory pathways. VMD Sciences is proud to be the first to broadly introduce these programs to the veterinary sector, providing new hope for pets when traditional treatments are no longer viable or available..

扩展获取计划（EAP），也称为管理获取或“同情使用”计划，已被广泛用于人类医学，以允许患者获得未经许可的疗法，通过监管途径解决未满足的医疗需求。VMD Sciences自豪地成为第一个将这些计划广泛引入兽医部门的人，当传统疗法不再可行或可用时，为宠物提供了新的希望。。

“We are thrilled to embark on this new venture in support of pets, veterinarians, and pet owners,” added Falcha. “Our leadership team brings over 100 years of diverse, global human health experience to meet this pressing need. By combining our expertise with top veterinary advisors and animal-focused pharmaceutical and biotechnology companies we aim to safely accelerate the development and accessibility of life-saving pet medicines.

Falcha补充道：“我们很高兴开始这项新的事业，以支持宠物、兽医和宠物主人。”。“我们的领导团队拥有100多年丰富的全球人类健康经验，以满足这一迫切需求。通过将我们的专业知识与顶级兽医顾问以及以动物为中心的制药和生物技术公司相结合，我们旨在安全地加速救生宠物药的开发和普及。

This initiative holds the potential to enhance both animal and human well-being through translational medicine.”.

这一举措具有通过转化医学提高动物和人类福祉的潜力。”。

VMD Sciences operates through two core functions to assist pets and vets while advancing science:

VMD Sciences通过两个核心功能来帮助宠物和兽医，同时推进科学发展：

Ethical Drug Sourcing: The company supports ethical and legal sourcing of global drugs from territories where they are licensed and supplies them to domestic regions where they are not yet approved.

道德药品采购：该公司支持全球药品从获得许可的地区进行道德和法律采购，并将其供应给尚未获得批准的国内地区。

Community Veterinarian Scientific Engagement: The company supports its expanding global network of community veterinarians by providing clinical study opportunities, AI-driven software, and logistical support for potential participation in companion animal clinical trials.

社区兽医科学参与：该公司通过提供临床研究机会，AI驱动的软件以及潜在参与伴侣动物临床试验的后勤支持，支持其不断扩大的全球社区兽医网络。

VMD Sciences has developed a robust global network for approved drug distribution. Treating veterinarians can initiate unsolicited product inquiries directly through the company’s website at vmdsciences.com, creating a seamless process for obtaining life-saving treatments for animals.

VMD Sciences为批准的药物分销开发了一个强大的全球网络。治疗兽医可以直接通过公司网站vmdsciences.com发起未经请求的产品查询，为获得动物救生治疗创造了一个无缝的过程。

About VMD Sciences, LLC

关于VMD Sciences，LLC

Veterinariae Medicinae Doctoris: VMD Sciences’ mission is to safely accelerate biomedical innovation for the benefit of pets, vets, and pet owners through direct scientific partnership with community veterinarians who “…have been an overlooked component of the physician-scientist workforce”, according to the NIH Physician-Scientist Workforce Working Group Report.

兽医医学博士：VMD Sciences的使命是通过与社区兽医的直接科学合作，安全地加速生物医学创新，以造福宠物，兽医和宠物主人，根据NIH医生-科学家劳动力工作组的报告，社区兽医“…一直是医生-科学家劳动力中被忽视的组成部分”。

The VMD Sciences Community Veterinarian Network provides members access to promising global medicines and allows them opportunities to provide clinical trials as potential care for animals in need..

VMD科学社区兽医网络为成员提供了有前途的全球药物，并使他们有机会提供临床试验，作为对有需要的动物的潜在护理。。